Insane trading levels. Might be another big day tomorrowDisallowed.asia/2020/04/10-asx-companies-that-performed-on-top-today/
• Mesoblast Soars to Five-Year High as there was a trial update last week. That trial was for its allogeneic mesenchymal stem cell product candidate remestemcel-L in ventilator-dependent COVID-19 patients. The release shows that the product achieved an 83% survival rate in ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome (SARDS). This is significantly better than the standard of care treatment
MESOBLAST - GVHD - A BIRD IN THE HAND, page-23
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |